Novartis Pharma GmbH (release of the finished medicinal product)/Novartis Pharmaceuticals, S.A. (release of the finished medicinal product)

Ukraine

All drugs from this manufacturer

  • SIMULECT

    The drug is used for the prevention of acute kidney rejection during kidney transplantation in adults and children aged 1 to 17 years.

    Dosage form: powder for solution for injection/infusion

    Active substance Dosage
    basiliximab 20 mg

    ATC: L04AC02